NASDAQ:ISRG - Intuitive Surgical Stock Price, Price Target & More

$462.71 -8.32 (-1.77 %)

(As of 04/20/2018 02:42 AM ET)

Previous Close$471.03

Today's Range$458.18 - $468.00

52-Week Range$267.62 - $473.79

Volume1.71 million shs

Average Volume884,712 shs

Market Capitalization$49.23 billion

P/E Ratio64.35

Dividend YieldN/A

Beta0.57

About Intuitive Surgical (NASDAQ:ISRG)

Intuitive Surgical, Inc. designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. The company's da Vinci surgical System translates a surgeon's natural hand movements, which are performed on instrument controls at a console into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports. Its da Vinci surgical system include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures. The company also manufactures EndoWrist instruments that include forceps, scissors, electrocautery, scalpels, and other surgical tools, which incorporate wrist joints for natural dexterity for various surgical procedures. In addition, it offers da Vinci Single-Site instruments and accessories that allow surgical systems to work through a single incision; and EndoWrist One vessel sealers that are wristed single-use instruments intended for bipolar coagulation and mechanical transection of vessels up to 7 mm in diameter and tissue bundles that fit in the jaws of the instrument. Further, the company provides EndoWrist stapler, a wristed stapling instrument intended for resection, transection, and/or creation of anastomoses, as well as sells various accessories, including replacement 3-D stereo endoscopes, camera heads, light guides, and other items that facilitate use of the da Vinci system, as well as sterile drapes for ensuring a sterile field during surgery. Intuitive Surgical, Inc. markets its products directly and through distributors in the United States, Europe, Asia, and internationally. The company was founded in 1995 and is headquartered in Sunnyvale, California.

Receive ISRG News and Ratings via Email

Sign-up to receive the latest news and ratings for ISRG and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical appliances & supplies

Sub-IndustryHealth Care Equipment

SectorMedical

SymbolNASDAQ:ISRG

CUSIP46120E60

Webwww.intuitivesurgical.com

Phone408-523-2100

Debt

Debt-to-Equity RatioN/A

Current Ratio3.99%

Quick Ratio3.65%

Price-To-Earnings

Trailing P/E Ratio64.35

Forward P/E Ratio58.94

P/E Growth5.19

Sales & Book Value

Annual Sales$3.13 billion

Price / Sales16.72

Cash Flow$9.0816 per share

Price / Cash50.95

Book Value$42.19 per share

Price / Book10.97

Profitability

EPS (Most Recent Fiscal Year)$7.19

Net Income$660 million

Net Margins23.25%

Return on Equity21.56%

Return on Assets18.40%

Miscellaneous

Employees4,444

Outstanding Shares113,060,000

How to Become a New Pot Stock Millionaire

Intuitive Surgical (NASDAQ:ISRG) Frequently Asked Questions

What is Intuitive Surgical's stock symbol?

Intuitive Surgical trades on the NASDAQ under the ticker symbol "ISRG."

When did Intuitive Surgical's stock split? How did Intuitive Surgical's stock split work?

Intuitive Surgical shares split on the morning of Friday, October 6th 2017. The 3-1 split was announced on Friday, August 11th 2017. The newly minted shares were distributed to shareholders after the market closes on Thursday, October 5th 2017. An investor that had 100 shares of Intuitive Surgical stock prior to the split would have 300 shares after the split.

How were Intuitive Surgical's earnings last quarter?

Intuitive Surgical (NASDAQ:ISRG) released its quarterly earnings data on Tuesday, April, 17th. The medical equipment provider reported $2.44 earnings per share for the quarter, beating the consensus estimate of $2.07 by $0.37. The medical equipment provider had revenue of $848 million for the quarter, compared to analysts' expectations of $773.20 million. Intuitive Surgical had a return on equity of 21.56% and a net margin of 23.25%. Intuitive Surgical's quarterly revenue was up 25.8% on a year-over-year basis. During the same period in the previous year, the firm earned $5.09 earnings per share. View Intuitive Surgical's Earnings History.

What price target have analysts set for ISRG?

17 brokers have issued 12 month target prices for Intuitive Surgical's stock. Their forecasts range from $225.00 to $525.00. On average, they expect Intuitive Surgical's share price to reach $430.8552 in the next twelve months. View Analyst Ratings for Intuitive Surgical.

What are Wall Street analysts saying about Intuitive Surgical stock?

Here are some recent quotes from research analysts about Intuitive Surgical stock:

1. According to Zacks Investment Research, "Over the last three months, Intuitive Surgical outperformed its industry. The company registered solid growth in the Mature and Growth procedures, especially in general and thoracic surgery. Intuitive Surgical’s da Vinci surgical robotic system will be the key growth driver, providing it with a competitive edge in the MedTech. The company's procedure performance in Asia showed continued strength with solid growth in China, Japan and Korea. A positive outlook for the coming quarters also raises our confidence. Further, incremental spending on product development and higher investments in international markets are likely to drive long-term growth. However, a surge in operating expenses is likely to keep margins under pressure. Further, the da Vinci Surgical System has a long sale and purchase order cycle. Cutthroat competition in the niche space is a concern. Forex woes are an added headwind for the company. " (3/27/2018)
2. Cantor Fitzgerald analysts commented, "Top-line results in-line with prelim results; EPS beat. ISRG reported 4Q top-line results consistent with its pre-announcement, including revenue of $892MM (+18%), and procedure growth of 16%. Adj. 4Q EPS was $2.54, beating FactSet consensus by $0.30 on higher-than-expected revenue, better- than-expected margins and a lower tax rate." (1/26/2018)

Who are some of Intuitive Surgical's key competitors?

Some companies that are related to Intuitive Surgical include Edwards Lifesciences (EW), Zimmer Biomet (ZBH), Align Technology (ALGN), Coloplast A/S (CLPBY), Smith & Nephew (SNN), William Demant (WILYY), STERIS (STE), Mine Safety Appliances (MSA), Inogen (INGN), Halyard Health (HYH), Wright Medical Group (WMGI), Consort Medical (CSRMY), Invacare (IVC), RTI Surgical (RTIX), Sientra (SIEN), Lakeland Industries (LAKE), ConforMIS (CFMS) and Histogenics (HSGX).

Who are Intuitive Surgical's key executives?

Intuitive Surgical's management team includes the folowing people:

Dr. Gary S. Guthart, CEO, Pres & Director (Age 52)
Mr. Marshall L. Mohr, Sr. VP & CFO (Age 62)
Mr. Salvatore J. Brogna, Exec. VP & COO (Age 63)
Mr. Mark J. Meltzer, Sr. VP, Gen. Counsel & Chief Compliance Officer (Age 68)
Mr. David J. Rosa, Exec. VP & Chief Commercial Officer (Age 50)

Has Intuitive Surgical been receiving favorable news coverage?

Headlines about ISRG stock have been trending positive recently, according to Accern Sentiment. The research firm ranks the sentiment of press coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Intuitive Surgical earned a daily sentiment score of 0.36 on Accern's scale. They also assigned press coverage about the medical equipment provider an impact score of 48.19 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company's share price in the near term.

How do I buy shares of Intuitive Surgical?

Shares of ISRG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Intuitive Surgical's stock price today?

One share of ISRG stock can currently be purchased for approximately $462.71.

How big of a company is Intuitive Surgical?

Intuitive Surgical has a market capitalization of $49.23 billion and generates $3.13 billion in revenue each year. The medical equipment provider earns $660 million in net income (profit) each year or $7.19 on an earnings per share basis. Intuitive Surgical employs 4,444 workers across the globe.

How can I contact Intuitive Surgical?

Intuitive Surgical's mailing address is 1020 KIFER ROAD, SUNNYVALE CA, 94086. The medical equipment provider can be reached via phone at 408-523-2100 or via email at [email protected]

MarketBeat Community Rating for Intuitive Surgical (ISRG)

Community Ranking:		2.9 out of 5 ( )
Outperform Votes:		647 (Vote Outperform)
Underperform Votes:		477 (Vote Underperform)
Total Votes:		1,124

MarketBeat's community ratings are surveys of what our community members think about Intuitive Surgical and other stocks. Vote "Outperform" if you believe ISRG will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ISRG will underperform the S&P 500 over the long term. You may vote once every thirty days.

Intuitive Surgical (NASDAQ:ISRG) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

17 Wall Street analysts have issued ratings and price targets for Intuitive Surgical in the last 12 months. Their average twelve-month price target is $430.8552, suggesting that the stock has a possible downside of 6.88%. The high price target for ISRG is $525.00 and the low price target for ISRG is $225.00. There are currently 4 hold ratings and 13 buy ratings for the stock, resulting in a consensus rating of "Buy."

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	Buy	Buy	Buy	Buy
Consensus Rating Score:	2.76	2.71	2.75	2.69
Ratings Breakdown:	0 Sell Rating(s) 4 Hold Rating(s) 13 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 5 Hold Rating(s) 12 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 4 Hold Rating(s) 12 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 5 Hold Rating(s) 11 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	$430.8552	$406.1342	$361.6231	$328.1778
Price Target Upside:	6.88% downside	1.25% upside	16.53% downside	8.19% downside

Intuitive Surgical (NASDAQ:ISRG) Consensus Price Target History

Price Target History for Intuitive Surgical (NASDAQ:ISRG)

Intuitive Surgical (NASDAQ:ISRG) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
4/18/2018	Bank of America	Boost Price Target	Buy -> Buy	$465.00 -> $510.00	Low
4/18/2018	Canaccord Genuity	Boost Price Target	Buy -> Buy	$410.00 -> $430.00	High
4/18/2018	Royal Bank of Canada	Set Price Target	Hold	$460.00	High
4/18/2018	Morgan Stanley	Boost Price Target	Overweight -> Overweight	$500.00 -> $525.00	High
4/18/2018	Stifel Nicolaus	Boost Price Target	Buy -> Buy	$480.00 -> $515.00	High
4/18/2018	Leerink Swann	Reiterated Rating	Outperform	$475.00 -> $510.00	High
4/18/2018	Cantor Fitzgerald	Boost Price Target	Overweight	$510.00	High
4/18/2018	Piper Jaffray	Boost Price Target	Neutral	$460.00	High
2/6/2018	Citigroup	Lower Price Target	Buy -> Buy	$507.00	Medium
1/26/2018	Barclays	Boost Price Target	Overweight -> Overweight	$475.00	High
1/3/2018	Evercore ISI	Initiated Coverage	In -> In-Line	$380.00	High
11/18/2017	Goldman Sachs	Reiterated Rating	Buy		N/A
10/16/2017	Wells Fargo	Reiterated Rating	Buy		N/A
10/10/2017	Wedbush	Reiterated Rating	Buy		N/A
7/21/2017	JPMorgan Chase	Reiterated Rating	Overweight	$350.01	High
6/15/2017	BTIG Research	Reiterated Rating	Hold		Low
4/25/2017	Jefferies Group	Reiterated Rating	Buy	$225.00	Low
8/26/2016	Raymond James	Initiated Coverage	Outperform		N/A
7/21/2016	Northland Securities	Downgrade		$200.00	N/A

(Data available from 4/20/2016 forward)

Intuitive Surgical (NASDAQ:ISRG) Earnings History and Estimates Chart

Earnings by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Intuitive Surgical (NASDAQ:ISRG) Earnings Estimates

Current Year EPS Consensus Estimate: $7.85 EPS
Next Year EPS Consensus Estimate: $8.51 EPS

Intuitive Surgical (NASDAQ ISRG) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
4/17/2018	Q1 2018	$2.07	$2.44	$773.20 million	$848.00 million	View	N/A
1/25/2018	n/a	$2.27	$2.54	$866.54 million	$892.40 million	View	Listen
10/19/2017	Q3 2017	$1.99	$2.77	$753.25 million	$806.10 million	View	N/A
7/20/2017	Q2 2017	$0.6433	$0.6611	$724.51 million	$756.20 million	View	N/A
4/18/2017	Q1 17	$0.4411	$0.5656	$664.72 million	$674.20 million	View	N/A
1/24/2017	Q416	$0.6656	$0.6767	$739.65 million	$757.00 million	View	N/A
10/18/2016	Q3	$0.57	$0.6878	$650.49 million	$682.90 million	View	Listen
7/19/2016	Q216	$0.5522	$0.6244	$640.69 million	$670.00 million	View	Listen
4/19/2016	Q1	$0.4811	$0.4911	$593.08 million	$594.50 million	View	Listen
1/21/2016	Q4	$0.56	$0.6544	$655.32 million	$676.50 million	View	Listen
10/20/2015	Q3	$0.47	$0.5822	$580.37 million	$590.00 million	View	Listen
7/21/2015	Q2	$0.4422	$0.5078	$566.86 million	$586.10 million	View	Listen
4/21/2015	Q1	$0.3167	$0.3967	$535.10 million	$532.10 million	View	Listen
1/22/2015	Q4	$0.3811	$0.4644	$599.17 million	$604.70 million	View	Listen
10/21/2014	Q314	$0.2978	$0.4356	$515.44 million	$550.00 million	View	Listen
7/22/2014	Q214	$0.3067	$0.3078	$502.23 million	$512.00 million	View	Listen
4/22/2014	Q114	$0.3711	$0.2967	$507.04 million	$464.70 million	View	Listen
1/23/2014	Q413	$0.4233	$0.4756	$576.00 million	$576.20 million	View	Listen
10/17/2013	Q313	$0.3778	$0.4433	$525.47 million	$499.00 million	View	Listen
7/18/2013	Q2 2013	$0.4489	$0.4333	$594.58 million	$578.50 million	View	Listen
4/18/2013	Q1 2013	$0.4467	$0.5067	$583.59 million	$611.40 million	View	Listen
1/22/2013	Q4 2012	$0.4467	$0.4722	$584.36 million	$609.30 million	View	Listen
10/16/2012		$0.39	$0.4956			View	N/A
7/19/2012		$0.3967	$0.4167			View	N/A
4/17/2012		$0.35	$0.3889			View	N/A
1/19/2012		$0.3722	$0.4167			View	N/A
10/18/2011		$0.3122	$0.3389			View	N/A
7/19/2011		$0.3011	$0.3233			View	N/A
4/19/2011		$0.2767	$0.2878			View	N/A
1/20/2011		$0.25	$0.3356			View	N/A
10/19/2010	Q3 2010	$0.70	$0.71			View	N/A
7/21/2010	Q2 2010	$0.68	$0.73			View	N/A
4/15/2010	Q1 2010	$0.55	$0.71			View	N/A
1/21/2010	Q4 2009	$0.57	$0.65			View	N/A
10/20/2009	Q3 2009	$0.48	$0.55			View	N/A
7/22/2009	Q2 2009	$0.42	$0.54			View	N/A
4/16/2009	Q1 2009	$0.35	$0.34			View	N/A
1/22/2009	Q4 2008	$0.43	$0.42			View	N/A
10/16/2008	Q3 2008	$0.42	$0.48			View	N/A
7/22/2008	Q2 2008	$0.39	$0.43			View	N/A
4/17/2008	Q1 2008	$0.33	$0.37			View	N/A
1/31/2008	Q4 2007	$0.34	$0.41			View	N/A

(Earnings results data provided by Zacks Investment Research)

Intuitive Surgical (NASDAQ:ISRG) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date

(Data available from 1/1/2013 forward)

Intuitive Surgical (NASDAQ ISRG) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 2.20%
Institutional Ownership Percentage: 87.89%

Insider Trading History for Intuitive Surgical (NASDAQ:ISRG)

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Intuitive Surgical (NASDAQ ISRG) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/5/2018	Mark J Rubash	Director	Sell	1,000	$420.01	$420,010.00	4,453
3/1/2018	Salvatore Brogna	COO	Sell	7,934	$421.37	$3,343,149.58	6,159
2/27/2018	Mark J Meltzer	SVP	Sell	24,000	$433.00	$10,392,000.00	34,052
2/20/2018	Jamie Samath	VP	Sell	861	$420.09	$361,697.49	1,232
2/20/2018	Mark J Meltzer	SVP	Sell	6,000	$419.98	$2,519,880.00	11,552
2/7/2018	Gary S Guthart	CEO	Sell	7,724	$414.50	$3,201,598.00	275,220
2/5/2018	Gary S Guthart	CEO	Sell	28,525	$414.50	$11,823,612.50	311,469
2/5/2018	Marshall Mohr	CFO	Sell	7,500	$414.19	$3,106,425.00	13,816
1/30/2018	Curet Myriam	EVP	Sell	262	$431.50	$113,053.00	2,152
1/30/2018	Jamie Samath	VP	Sell	964	$428.60	$413,170.40	118
1/30/2018	Lonnie M Smith	Director	Sell	18,000	$428.68	$7,716,240.00	511,410
12/1/2017	Jamie Samath	VP	Sell	959	$398.46	$382,123.14	536
12/1/2017	Mark J Rubash	Director	Sell	6,000	$395.95	$2,375,700.00	5,453
12/1/2017	Salvatore Brogna	COO	Sell	6,082	$397.61	$2,418,264.02	3,096
11/27/2017	Mark J Meltzer	SVP	Sell	3,000	$400.00	$1,200,000.00	9,888
11/21/2017	Mark J Meltzer	SVP	Sell	6,000	$397.14	$2,382,840.00	9,888
11/10/2017	Lonnie M Smith	Director	Sell	580	$386.76	$224,320.80	559,410
10/30/2017	Marshall Mohr	CFO	Sell	6,000	$372.22	$2,233,320.00	12,316
10/26/2017	Craig H Barratt	Insider	Sell	7,500	$381.00	$2,857,500.00	7,500
10/24/2017	Alan J. Levy	Director	Sell	2,997	$371.35	$1,112,935.95
10/24/2017	Craig H Barratt	Insider	Sell	15,000	$371.18	$5,567,700.00	7,500
10/24/2017	Curet Myriam	SVP	Sell	262	$373.00	$97,726.00
10/24/2017	Jamie Samath	VP	Sell	1,564	$371.19	$580,541.16
9/5/2017	Mark J Meltzer	SVP	Sell	500	$1,025.00	$512,500.00	2,796
9/1/2017	Salvatore Brogna	EVP	Sell	899	$1,001.90	$900,708.10	570
8/31/2017	Keith R Leonard	Director	Sell	854	$1,000.00	$854,000.00	754
8/22/2017	Mark J Meltzer	SVP	Sell	500	$982.90	$491,450.00	2,796
7/27/2017	Gary S Guthart	CEO	Sell	17,975	$937.27	$16,847,428.25	101,798
7/25/2017	Curet Myriam	SVP	Sell	1,202	$950.20	$1,142,140.40	1,428
7/25/2017	Jamie Samath	VP	Sell	242	$949.01	$229,660.42	23
7/25/2017	Michael A Friedman	Director	Sell	1,000	$945.60	$945,600.00	977
6/12/2017	Mark J Meltzer	SVP	Sell	3,000	$887.09	$2,661,270.00	3,046
6/8/2017	Mark J Rubash	Director	Sell	3,000	$931.51	$2,794,530.00	4,151
6/7/2017	Curet Myriam	SVP	Sell	750	$930.00	$697,500.00	1,428
6/5/2017	Curet Myriam	SVP	Sell	2,644	$921.26	$2,435,811.44	1,428
6/5/2017	Jamie Samath	VP	Sell	1,946	$921.26	$1,792,771.96	130
6/1/2017	Salvatore Brogna	EVP	Sell	1,306	$915.09	$1,195,107.54	977
5/31/2017	Amal M Johnson	Director	Sell	1,000	$917.27	$917,270.00	3,787
5/5/2017	Jamie Samath	VP	Sell	48	$850.00	$40,800.00
5/2/2017	Curet Myriam	SVP	Sell	3,385	$837.21	$2,833,955.85	2,657
4/27/2017	Marshall Mohr	CFO	Sell	8,950	$835.89	$7,481,215.50	6,422
4/25/2017	Jamie Samath	VP	Sell	626	$825.00	$516,450.00	94
4/24/2017	Alan J Levy	Director	Sell	1,386	$813.15	$1,127,025.90	2,598
4/21/2017	David J. Rosa	EVP	Sell	5,000	$810.52	$4,052,600.00	8,222
4/21/2017	Gary S Guthart	CEO	Sell	18,775	$810.33	$15,213,945.75	95,573
4/21/2017	Jamie Samath	VP	Sell	490	$811.67	$397,718.30	48
4/21/2017	Lonnie M Smith	Director	Sell	3,000	$810.12	$2,430,360.00	232,638
3/15/2017	Amal M Johnson	Director	Sell	1,000	$750.00	$750,000.00	3,460
3/15/2017	David J Rosa	EVP	Sell	5,000	$750.00	$3,750,000.00	8,222
3/15/2017	Jamie Samath	VP	Sell	4,268	$750.00	$3,201,000.00	896
3/15/2017	Marshall Mohr	CFO	Sell	4,250	$750.00	$3,187,500.00	4,422
3/1/2017	Salvatore Brogna	EVP	Sell	6,628	$736.80	$4,883,510.40	1,990
2/24/2017	Curet Myriam	SVP	Sell	222	$729.80	$162,015.60	762
2/21/2017	Mark J Meltzer	SVP	Sell	8,750	$724.82	$6,342,175.00	2,274
2/7/2017	Colin Morales	SVP	Sell	1,000	$703.99	$703,990.00	1,124
2/2/2017	Marshall Mohr	CFO	Sell	2,000	$700.00	$1,400,000.00	3,289
1/27/2017	Lonnie M Smith	Director	Sell	1,000	$684.38	$684,380.00	234,971
12/13/2016	David J Rosa	EVP	Sell	7,200	$650.00	$4,680,000.00	2,187
12/13/2016	Lonnie M Smith	Director	Sell	1,000	$650.00	$650,000.00	235,971
11/17/2016	Lonnie M Smith	Director	Sell	275	$646.50	$177,787.50	235,890
11/7/2016	Gary S Guthart	CEO	Sell	13,515	$680.68	$9,199,390.20	82,880
8/22/2016	Mark J Meltzer	SVP	Sell	3,000	$688.33	$2,064,990.00	2,331
8/4/2016	Alan J Levy	Director	Sell	3,188	$694.11	$2,212,822.68	5,401
8/1/2016	Gary S Guthart	CEO	Sell	13,400	$698.00	$9,353,200.00	78,780
7/27/2016	Curet Myriam	SVP	Sell	4,250	$684.39	$2,908,657.50	3,133
7/27/2016	Marshall Mohr	CFO	Sell	5,000	$684.09	$3,420,450.00	6,725
6/2/2016	Salvatore Brogna	EVP	Sell	600	$630.96	$378,576.00	421
6/1/2016	Salvatore Brogna	EVP	Sell	20,406	$632.66	$12,910,059.96	796
5/17/2016	Curet Myriam	SVP	Sell	530	$629.36	$333,560.80	133
5/17/2016	Lonnie M Smith	Director	Sell	2,000	$627.23	$1,254,460.00	264,644
5/3/2016	George Stalk Jr	Director	Sell	7,644	$618.70	$4,729,342.80	2,026
5/2/2016	Marshall Mohr	CFO	Sell	5,000	$631.63	$3,158,150.00	6,121
4/27/2016	Mark J Meltzer	SVP	Sell	16,625	$631.52	$10,499,020.00	14,081
4/26/2016	Alan J Levy	Director	Sell	542	$631.72	$342,392.24	2,213
4/25/2016	Amal M Johnson	Director	Sell	2,500	$640.00	$1,600,000.00	4,960
4/22/2016	Curet Myriam	SVP	Sell	8,173	$637.75	$5,212,330.75	6,263
4/22/2016	Eric H Halvorson	Director	Sell	5,688	$639.21	$3,635,826.48	2,485
3/14/2016	Eric H Halvorson	Director	Sell	4,438	$593.16	$2,632,444.08	4,775
3/14/2016	Mark J Meltzer	SVP	Sell	12,500	$589.00	$7,362,500.00	14,081
3/11/2016	Curet Myriam	SVP	Sell	2,000	$582.50	$1,165,000.00	2,663
3/11/2016	Jamie Samath	VP	Sell	8,026	$575.95	$4,622,574.70	1,370
3/10/2016	Alan J Levy	Director	Sell	5,000	$569.14	$2,845,700.00	7,213
3/7/2016	Colin Morales	SVP	Sell	2,500	$575.00	$1,437,500.00	2,574
3/4/2016	Colin Morales	SVP	Sell	884	$571.49	$505,197.16	958
3/3/2016	Marshall Mohr	CFO	Sell	2,500	$575.00	$1,437,500.00	3,621
3/2/2016	Salvatore Brogna	EVP	Sell	1,882	$567.37	$1,067,790.34	1,912
2/19/2016	Colin Morales	SVP	Sell	5,530	$542.83	$3,001,849.90	128
2/4/2016	Curet Myriam	SVP	Sell	2,000	$551.00	$1,102,000.00	163
2/4/2016	Marshall Mohr	CFO	Sell	2,500	$550.00	$1,375,000.00	535
1/29/2016	Mark J. Meltzer	SVP	Sell	4,125	$527.59	$2,176,308.75	996
12/14/2015	Salvatore Brogna	EVP	Sell	2,734	$530.00	$1,449,020.00	692
11/20/2015	Mark J. Meltzer	SVP	Sell	1,625	$515.00	$836,875.00	996
10/26/2015	Mark J. Meltzer	SVP	Sell	2,500	$498.37	$1,245,925.00	996
10/23/2015	Lonnie M. Smith	Director	Sell	10,328	$500.00	$5,164,000.00	265,159
9/1/2015	Salvatore Brogna	EVP	Sell	374	$501.99	$187,744.26	692
8/18/2015	George Stalk Jr	Director	Sell	4,726	$532.03	$2,514,373.78
7/27/2015	Gary S Guthart	CEO	Sell	17,255	$541.98	$9,351,864.90
7/27/2015	Mark J Meltzer	SVP	Sell	4,750	$542.03	$2,574,642.50
7/24/2015	David J Rosa	EVP	Sell	2,800	$550.20	$1,540,560.00
7/24/2015	Jamie Samath	VP	Sell	5,000	$550.00	$2,750,000.00
7/24/2015	Lonnie M Smith	Director	Sell	20,000	$544.62	$10,892,400.00
6/9/2015	Alan J Levy	Director	Sell	417	$495.41	$206,585.97
6/8/2015	Gary S Guthart	CEO	Sell	17,840	$492.16	$8,780,134.40
5/29/2015	Lonnie M Smith	Director	Sell	2,000	$488.68	$977,360.00
5/27/2015	Curet Myriam	SVP	Sell	1,000	$489.35	$489,350.00
5/18/2015	Colin Morales	SVP	Sell	13,824	$503.29	$6,957,480.96
4/28/2015	Curet Myriam	SVP	Sell	261	$504.54	$131,684.94
4/27/2015	Jerome J Mcnamara	EVP	Sell	15,000	$504.06	$7,560,900.00
4/27/2015	Marshall Mohr	CFO	Sell	10,000	$504.08	$5,040,800.00
4/24/2015	Lonnie M Smith	Director	Sell	20,000	$508.03	$10,160,600.00
3/2/2015	Salvatore Brogna	SVP	Sell	1,375	$500.98	$688,847.50
2/6/2015	Mark J Rubash	Director	Sell	5,000	$520.00	$2,600,000.00
1/27/2015	Jerome J Mcnamara	EVP	Sell	15,000	$511.32	$7,669,800.00
1/27/2015	Lonnie M Smith	Director	Sell	20,000	$511.31	$10,226,200.00
1/27/2015	Marshall Mohr	CFO	Sell	5,000	$511.14	$2,555,700.00
12/8/2014	Lonnie M Smith	Director	Sell	1,700	$511.24	$869,108.00
12/1/2014	Salvatore Brogna	SVP	Sell	1,375	$515.87	$709,321.25
11/24/2014	Colin Morales	SVP	Sell	9,565	$520.82	$4,981,643.30
10/31/2014	Marshall Mohr	CFO	Sell	7,500	$500.00	$3,750,000.00
10/30/2014	Floyd D Md Loop	Director	Sell	2,125	$488.95	$1,039,018.75
10/27/2014	Floyd D Md Loop	Director	Sell	15,209	$475.71	$7,235,073.39
10/27/2014	Jerome J Mcnamara	EVP	Sell	15,000	$473.76	$7,106,400.00
10/27/2014	Marshall Mohr	CFO	Sell	2,500	$473.50	$1,183,750.00
9/2/2014	Salvatore Brogna	SVP	Sell	12,626	$472.06	$5,960,229.56
8/26/2014	Colin Morales	SVP	Sell	4,105	$478.66	$1,964,899.30
7/28/2014	Jerome J Mcnamara	EVP	Sell	9,167	$465.59	$4,268,063.53
7/25/2014	Colin Morales	SVP	Sell	2,000	$461.99	$923,980.00
2/27/2014	Colin Morales	SVP	Sell	1,000	$445.00	$445,000.00	76
12/3/2012	Lonnie M Smith	Chairman	Sell	1,000	$525.98	$525,980.00
9/4/2012	Salvatore Brogna	SVP	Sell	1,250	$490.25	$612,812.50

(Data available from 1/1/2013 forward)

Intuitive Surgical (NASDAQ ISRG) News Headlines

Source:

Date	Headline
	Canaccord Genuity Reiterates Hold Rating for Intuitive Surgical (ISRG) www.americanbankingnews.com - April 19 at 6:54 PM
	Intuitive Surgical (ISRG) Given Average Rating of "Buy" by Brokerages www.americanbankingnews.com - April 19 at 3:32 PM
	Intuitive Surgical: S&P 500’s Top Gainer on April 18 finance.yahoo.com - April 19 at 8:37 AM
	International Headwinds Can't Slow Intuitive Surgical Inc. www.fool.com - April 18 at 5:28 PM
	Intuitive Surgical (ISRG) Q1 2018 Earnings Conference Call Transcript www.msn.com - April 18 at 5:28 PM
	International Headwinds Can't Slow Intuitive Surgical Inc. finance.yahoo.com - April 18 at 5:28 PM
	Bank of America Raises Intuitive Surgical (ISRG) Price Target to $510.00 www.americanbankingnews.com - April 18 at 2:28 PM
	Analyst: Intuitive Surgical Is Moving Into Its 'Most Catalyst Rich' Cycle Ever feeds.benzinga.com - April 18 at 1:52 PM
	Intuitive Surgical (ISRG) PT Raised to $430.00 at Canaccord Genuity www.americanbankingnews.com - April 18 at 10:38 AM
	Intuitive Surgical (ISRG) PT Raised to $525.00 at Morgan Stanley www.americanbankingnews.com - April 18 at 10:10 AM
	Intuitive Surgical (ISRG) Given a $460.00 Price Target at Royal Bank of Canada www.americanbankingnews.com - April 18 at 9:53 AM
	Intuitive Surgical (ISRG) Receives "Buy" Rating from Stifel Nicolaus www.americanbankingnews.com - April 18 at 9:51 AM
	Intuitive Surgical (ISRG) Rating Reiterated by Leerink Swann www.americanbankingnews.com - April 18 at 9:51 AM
	Intuitive Surgical (ISRG) PT Raised to $460.00 www.americanbankingnews.com - April 18 at 9:00 AM
	Intuitive Surgical (ISRG) Price Target Increased to $510.00 by Analysts at Cantor Fitzgerald www.americanbankingnews.com - April 18 at 9:00 AM
	Intuitive Surgical's (ISRG) CEO Gary Guthart on Q1 2018 Results - Earnings Call Transcript seekingalpha.com - April 18 at 8:36 AM
	Today’s Research Reports on Stocks to Watch: Intuitive Surgical and Rigel Pharmaceuticals finance.yahoo.com - April 18 at 8:36 AM
	Intuitive Surgical (ISRG) Posts Earnings Results, Beats Expectations By $0.37 EPS www.americanbankingnews.com - April 17 at 9:03 PM
	Intuitive Surgical (ISRG) PT Raised to $316.68 at Royal Bank of Canada www.americanbankingnews.com - April 17 at 7:34 PM
	Intuitive Surgical, Inc. (ISRG) May Top Record High on Strong Earnings investorplace.com - April 17 at 6:39 PM
	Intuitive Surgical Inc. Q1 adjusted earnings Beat Estimates www.nasdaq.com - April 17 at 5:40 PM
	Intuitive Surgical Q1 Worldwide Da Vinci Procedures Up Approx. 15% www.nasdaq.com - April 17 at 5:40 PM
	Intuitive Surgical Q1 top line off 5%; non-GAAP earnings down 6%; shares up 5% after hours consensus beat www.msn.com - April 17 at 5:40 PM
	Intuitive Surgical Announces First Quarter Earnings finance.yahoo.com - April 17 at 5:40 PM
	Intuitive Surgical, Inc. to Host Earnings Call finance.yahoo.com - April 17 at 5:40 PM
	What You Must Know About Intuitive Surgical Inc’s (NASDAQ:ISRG) ROE finance.yahoo.com - April 17 at 5:40 PM
	Intuitive Surgical beats on bottom line finance.yahoo.com - April 17 at 5:40 PM
	Intuitive Surgical stock surges toward record highs after earnings finance.yahoo.com - April 17 at 5:40 PM
	Intuitive Surgical's quarterly profit jumps 59 percent finance.yahoo.com - April 17 at 5:40 PM
	Intuitive Surgical Pops After Crushing First-Quarter Expectations finance.yahoo.com - April 17 at 5:40 PM
	Intuitive Surgical's profit tops estimates as da Vinci device sales soar finance.yahoo.com - April 17 at 5:40 PM
	5 of the Best Big Cap Earnings Charts finance.yahoo.com - April 17 at 8:11 AM
	Intuitive Surgical (ISRG) Downgraded to "Buy" at BidaskClub www.americanbankingnews.com - April 16 at 5:55 PM
	Intuitive Surgical Maintains Pattern of Posting Wider Follow-On Next Day Trade in Wake of Post-Market Earnings Moves www.nasdaq.com - April 16 at 5:38 PM
	Zacks Investment Research Upgrades Intuitive Surgical (ISRG) to "Strong-Buy" www.americanbankingnews.com - April 16 at 4:48 PM
	Can Instruments Drive Intuitive Surgical (ISRG) Q1 Earnings? www.zacks.com - April 16 at 9:09 AM
	Intuitive Surgical (ISRG) Lowered to "Hold" at BidaskClub www.americanbankingnews.com - April 14 at 5:18 PM
	Financial Survey: Lakeland Industries (LAKE) versus Intuitive Surgical (ISRG) www.americanbankingnews.com - April 13 at 7:19 PM
	[$$] Robotic-Surgery Pioneer Seeks Lung Cancer Revolution finance.yahoo.com - April 12 at 8:37 AM
	Investor Expectations to Drive Momentum within Xcerra, Grupo Aeroportuario del Centro Norte S.A.B. de C.V, WAVE Life Sciences, Hoegh LNG Partners LP, Mesoblast, and Intuitive Surgical — Discovering Underlying Factors of Influence finance.yahoo.com - April 11 at 8:29 AM
	Intuitive Surgical (ISRG) Downgraded by Vetr to "Hold" www.americanbankingnews.com - April 10 at 9:17 AM
	Intuitive Surgical (ISRG) Cut to "Buy" at Vetr www.americanbankingnews.com - April 10 at 7:31 AM
	Brokerages Anticipate Intuitive Surgical (ISRG) Will Post Quarterly Sales of $766.61 Million www.americanbankingnews.com - April 10 at 2:54 AM
	Noteworthy Monday Option Activity: MRK, DDD, ISRG www.nasdaq.com - April 9 at 5:35 PM
	Intuitive Surgical (ISRG) Stock Rating Reaffirmed by Morgan Stanley www.americanbankingnews.com - April 9 at 12:10 PM
	Intuitive Surgical (ISRG) Set to Announce Quarterly Earnings on Monday www.americanbankingnews.com - April 9 at 1:02 AM
	Brokerages Expect Intuitive Surgical (ISRG) to Announce $1.99 Earnings Per Share www.americanbankingnews.com - April 8 at 3:10 PM
	Intuitive Surgical (ISRG) Given "Buy" Rating at Wedbush www.americanbankingnews.com - April 7 at 6:04 PM
	Don't Waste Your Money on Cryptocurrencies -- These 3 Stocks Are Better Buys finance.yahoo.com - April 4 at 4:34 PM
	Don't Waste Your Money on Cryptocurrencies -- These 3 Stocks Are Better Buys finance.yahoo.com - April 4 at 4:34 PM

Intuitive Surgical (NASDAQ:ISRG) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

Intuitive Surgical (NASDAQ:ISRG) Income Statement, Balance Sheet and Cash Flow Statement

Intuitive Surgical (NASDAQ ISRG) Stock Chart for Friday, April, 20, 2018

Loading chart…

This page was last updated on 4/20/2018 by MarketBeat.com Staff